Evidence map›Paper›PMID 35041488›Full record

ArticleInfection and immunity2022

Protection Generated by Prior Exposure to Pathogens Depends on both Priming and Challenge Dose.

Chava L Weitzman, Guadalupe Ceja, Ariel E Leon, Dana M Hawley

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Chava L Weitzman *Department of Biological Sciences, Virginia Techgrid.438526.e, Blacksburg, Virginia, USA.ORCID 0000-0002-6103-1885
Guadalupe Ceja *Department of Biological Sciences, Virginia Techgrid.438526.e, Blacksburg, Virginia, USA.
Ariel E LeonDepartment of Biological Sciences, Virginia Techgrid.438526.e, Blacksburg, Virginia, USA.
Dana M HawleyDepartment of Biological Sciences, Virginia Techgrid.438526.e, Blacksburg, Virginia, USA.ORCID 0000-0001-9573-2914
Virginia Tech · US

Funding

VT Post Baccalaureate Research and Education ProgramR25GM066534 · NIGMS · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI SMITH, EDWARD J · 2003 to 2024
$7.6M
VT Initiative for Maximizing Student DiversityR25GM072767 · NIGMS · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI SMITH, EDWARD J · 2007 to 2021
$6.9M
Ecological and evolutionary causes and consequences of host heterogeneity induced by prior exposureR01GM144972 · NIGMS · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI HAWLEY, DANA M · 2021 to 2024
$2.0M
NIGMS NIH HHS R01 GM144972NIGMS NIH HHS R25 GM066534NIGMS NIH HHS R25 GM072767
6 · The paper itself

Abstract

Free-living hosts encounter pathogens at a wide range of frequencies and concentrations, including low doses that are largely aclinical, creating a varied landscape of exposure history and reinfection likelihood. While several studies show that higher priming doses result in stronger immunological protection against reinfection, it remains unknown how the reinfection challenge dose and priming dose interact to determine the likelihood and severity of reinfection. We manipulated both priming and challenge doses of Mycoplasma gallisepticum, which causes mycoplasmal conjunctivitis, in captive house finches (Haemorhous mexicanus), to assess reinfection probability and severity. We found a significant interaction between priming and challenge doses on reinfection probability, with the likelihood of reinfection by a high but not a low challenge dose decreasing exponentially at higher priming doses. While this interaction was likely driven by lower average infection probabilities for low-dose versus high-dose challenges, even the highest priming dose provided only negligible protection against reinfection from low-dose challenges. Similarly, pathogen loads during reinfection were significantly reduced with increasing priming doses only for birds reinfected at high but not low doses. We hypothesize that these interactions arise to some degree from fundamental differences in host immune responses across doses, with single low doses only weakly triggering host immune responses. Importantly, our results also demonstrate that reinfections can occur from a variety of exposure doses and across diverse degrees of standing immunity in this system. Overall, our study highlights the importance of considering both initial and subsequent exposure doses where repeated exposure to a pathogen is common in nature.

Indexed as

Bird DiseasesFinchesMycoplasma gallisepticumMycoplasma InfectionsAnimalsReinfectionhouse finchimmunological protectionMycoplasma gallisepticummycoplasmal conjunctivitisreinfection

Identifiers

PMID35041488
PMCPMC8929379
OpenAlexW4205334160

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.